Cyclacel Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CASI | C | CASI Pharmaceuticals, Inc. | -0.41 | |
CYCCP | F | Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | 2.74 | |
CYCC | F | Cyclacel Pharmaceuticals, Inc. | -3.41 |
Related Industries: Biotechnology
Related Stock Lists:
Cancer
Cell Cycle
Treatment Of Cancer
Autoimmune And Inflammatory Disease
Biology
Biopharmaceutical
Cancer Cell
Cdk Inhibitor
Cell Biology
Cell Cycle Checkpoint
Cyclin Dependent Kinase
Cyclin Dependent Kinase 2
Dna Synthesis
Human Cancers
Inflammatory Diseases
PLK1
Sapacitabine
Seliciclib
Advanced Solid Tumors
Autoimmune Disease
Related Industries:
Biotechnology
Related Stock Lists:
Cancer
Cell Cycle
Treatment Of Cancer
Autoimmune And Inflammatory Disease
Biology
Biopharmaceutical
Cancer Cell
Cdk Inhibitor
Cell Biology
Cell Cycle Checkpoint
Cyclin Dependent Kinase
Cyclin Dependent Kinase 2
Dna Synthesis
Human Cancers
Inflammatory Diseases
PLK1
Sapacitabine
Seliciclib
Advanced Solid Tumors
Autoimmune Disease
- Cyclacel
Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Dundee, Scotland, and Short Hills, New Jersey, developing cancer drugs and treatments. Cyclacel was founded in 1996 by David Lane, Merlin Ventures and Cancer Research Campaign Technology with the University of Dundee and the University of Glasgow.
Major shareholders include Goldman Sachs Group, Tang Capital Management, Redmile Group and Ayer Capital Management.
The firm is developing "mechanism-targeted drugs" to help in the fight of cancer, and other serious illness, such as diabetes and HIV.
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles